81 related articles for article (PubMed ID: 22500096)
1. CD24 expression as a marker for predicting clinical outcome in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
J Biomed Biotechnol; 2012; 2012():517172. PubMed ID: 22500096
[TBL] [Abstract][Full Text] [Related]
2. BMP4, a new prognostic factor for glioma.
Wu Q; Yao J
World J Surg Oncol; 2013 Oct; 11():264. PubMed ID: 24099560
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of JAM-A in gliomas.
Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
[TBL] [Abstract][Full Text] [Related]
4. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
5. New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways.
Martelli A; Omrani M; Zarghooni M; Citi V; Brogi S; Calderone V; Sureda A; Lorzadeh S; da Silva Rosa SC; Grabarek BO; Staszkiewicz R; Los MJ; Nabavi SF; Nabavi SM; Mehrbod P; Klionsky DJ; Ghavami S
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497321
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial delivery of CPI444 and vatalanib loaded on PEGylated graphene oxide as an effective nanoformulation to target glioblastoma multiforme:
Mishra VS; Patil S; Reddy PC; Lochab B
Front Oncol; 2022; 12():953098. PubMed ID: 36052261
[TBL] [Abstract][Full Text] [Related]
7. Review: New horizons in retinoblastoma treatment: an updated review article.
Azimi F; Mirshahi R; Naseripour M
Mol Vis; 2022; 28():130-146. PubMed ID: 36034735
[TBL] [Abstract][Full Text] [Related]
8. Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword.
Wu M; Shi Y; Zhu L; Chen L; Zhao X; Xu C
Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013403
[TBL] [Abstract][Full Text] [Related]
9. Angiogenin and plexin-B2 axis promotes glioblastoma progression by enhancing invasion, vascular association, proliferation and survival.
Yang H; Yuan L; Ibaragi S; Li S; Shapiro R; Vanli N; Goncalves KA; Yu W; Kishikawa H; Jiang Y; Hu AJ; Jay D; Cochran B; Holland EC; Hu GF
Br J Cancer; 2022 Aug; 127(3):422-435. PubMed ID: 35418212
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells.
Haddock S; Alban TJ; Turcan Ş; Husic H; Rosiek E; Ma X; Wang Y; Bale T; Desrichard A; Makarov V; Monette S; Wu W; Gardner R; Manova K; Boire A; Chan TA
Neoplasia; 2022 Jun; 28():100790. PubMed ID: 35398668
[TBL] [Abstract][Full Text] [Related]
11. Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma.
Tondepu C; Karumbaiah L
Adv Healthc Mater; 2022 Feb; 11(4):e2101956. PubMed ID: 34878733
[TBL] [Abstract][Full Text] [Related]
12. Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma.
Wu H; Liu J; Wang Z; Yuan W; Chen L
CNS Neurosci Ther; 2021 Oct; 27(10):1105-1117. PubMed ID: 34363319
[TBL] [Abstract][Full Text] [Related]
13. The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas.
Skowron MA; Becker TK; Kurz L; Jostes S; Bremmer F; Fronhoffs F; Funke K; Wakileh GA; Müller MR; Burmeister A; Lenz T; Stefanski A; Stühler K; Petzsch P; Köhrer K; Altevogt P; Albers P; Kristiansen G; Schorle H; Nettersheim D
Mol Oncol; 2022 Feb; 16(4):982-1008. PubMed ID: 34293822
[TBL] [Abstract][Full Text] [Related]
14. The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies.
Vartholomatos E; Vartholomatos G; Alexiou GA; Markopoulos GS
Methods Protoc; 2021 Jan; 4(1):. PubMed ID: 33530325
[TBL] [Abstract][Full Text] [Related]
15. Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme.
Mishra VS; Kumar N; Raza M; Sehrawat S
Oncotarget; 2020 Dec; 11(51):4754-4769. PubMed ID: 33473259
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells.
Papadopoulos F; Isihou R; Alexiou GA; Tsalios T; Vartholomatos E; Markopoulos GS; Sioka C; Tsekeris P; Kyritsis AP; Galani V
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33322363
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma.
Karnan S; Ota A; Murakami H; Rahman ML; Hasan MN; Wahiduzzaman M; Hanamura I; Quang Vu L; Inoko A; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y
Cell Death Discov; 2020 Nov; 6(1):127. PubMed ID: 33298865
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of CD24 in Cancer Theranostics-A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond.
Kleinmanns K; Fosse V; Bjørge L; McCormack E
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33260974
[TBL] [Abstract][Full Text] [Related]
19. Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer.
Zou W; Yang Y; Zheng R; Wang Z; Zeng H; Chen Z; Yang F; Wang J
Int J Clin Exp Pathol; 2020; 13(5):1008-1016. PubMed ID: 32509072
[TBL] [Abstract][Full Text] [Related]
20. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy.
Sun J; Feng D; Xi H; Luo J; Zhou Z; Liu Q; Chen Y; Shao Q
Mol Oncol; 2020 Aug; 14(8):1740-1759. PubMed ID: 32394616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
